You can now watch the recording of “Breaking New Ground: Once-Weekly Insulin“, an expert-led webinar exploring the evolution of long-acting insulin and new once-weekly formulations, only on the ATTD portal.
Gain practical insights and see what leading professionals had to say.
Webinar Highlights
- Topic: Breaking New Ground: Once-Weekly Insulin
- Date & Time: Monday, 10th February, at 15:00 CET
- Duration: 1 Hour
- Speakers: Prof. Stefano Del Prato, Dr. Carol Wysham and Dr. Diana Borges Duarte
Webinar Agenda
- Welcome and Introduction (10 min) by Diana Borges Duarte, MD
- Overview of Long-Acting Insulin Therapy (15 min). Evolution of insulin formulations (Glargine, Detemir) and benefits of long-acting insulin by Carol Wyshan, MD
- Focus on Once-Weekly Insulin (15 min). New formulations like Once-Weekly Basal Insulin FC and Insulin Icodec and practical considerations and patient selection by Prof. Stefano Del Prato, MD, PhD
- Q&A Session (20 min) with all speakers
Speakers
Prof. Stefano Del Prato
MD, Professor of Endocrinology
University of Pisa School of Medicine
Dr. Carol Wysham
MD, FACP, FACE
University of Washington School of Medicine
Carol H. Wysham, MD, FACP, FACE is a clinical endocrinologist at Multicare/Rockwood Clinic and Clinical Professor of Medicine at University of Washington School of Medicine in Spokane, Washington. Dr. Wysham chaired the Professional Practice Committee of the American Diabetes Association in 2011-2012 and served as co-chair and Chair of the Annual Meeting of the Endocrine Society from 2014 – 2016. She has more than 50 publications and over 30 years of clinical research experience, including site principal investigator on the SWITCH, ACCORD, TECOS, EMPA-REG, LEADER, EXCEL and CANVAS Trials. Dr. Wysham is on the Council of the Endocrine Society, is a member of the American Diabetes Association and a Fellow of both the American College of Endocrinology and the American College of Physicians.
Dr. Diana Borges Duarte
Endocrinologist
Hospital de Braga (Portugal)
Endocrinologist at the Department of Endocrinology, Hospital de Braga, Portugal. Clinical practitioner dedicated to type 1 diabetes, especially diabetes technologies (insulin pumps, smart pens, continuous glucose monitoring, DIY community), automated insulin delivery systems, and patient education. I aim to achieve the best medical care for persons with type 1 diabetes while strengthening disease knowledge and patient empowerment to reduce the burden of the disease.
This webinar is supported by Eli Lilly and Novo Nordisk A/S.
***IMPORTANT***
This webinar is supported by Eli Lilly and Novo Nordisk A/S. Please note that this activity is not available to participants from the United Kingdom due to regional restrictions. We appreciate your understanding, and we apologize for the inconvenience.
Stefano Del Prato, MD is Professor of Endocrinology and Metabolism at the University of Pisa School of Medicine and Chief of the Section of Diabetes, University of Pisa, Italy. He graduated MD cum laude from the University of Padova and undertook post graduate specialization in both Endocrinology and Internal Medicine. From 1988 through 1990 he was Associate Professor at the University of Texas, Health Science Center, San Antonio, TX, USA. Dr. Del Prato’s research interests have always been focused on diabetes and in particular the physiopathology and therapy of type 2 diabetes and insulin resistance syndrome.